Global Somatostatin Analogue Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2212260070 | Category: Pharma & Healthcare | Pages: 104 | Format: PDF | Published Date: February 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Somatostatin analogues are drugs that stop your body from making too many hormones. Some neuroendocrine tumours (NETs) make large amounts of hormones that cause a group of symptoms called carcinoid syndrome. Somatostatin analogues are a possible treatment for people with carcinoid syndrome.
According to our (Global Info Research) latest study, the global Somatostatin Analogue Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Somatostatin Analogue Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Somatostatin Analogue Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Somatostatin Analogue Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Somatostatin Analogue Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Somatostatin Analogue Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Somatostatin Analogue Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Somatostatin Analogue Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Camurus AB, Chiasma, Ipsen Group, Boehringer Ingelheim International GmbH and Eli Lilly & Co., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Somatostatin Analogue Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Octreotide
Lanreotide
Pasireotide
Market segment by Application
Acromegaly
Neuroendocrine Tumor (NET)
Others
Market segment by players, this report covers
Camurus AB
Chiasma
Ipsen Group
Boehringer Ingelheim International GmbH
Eli Lilly & Co.
F. Hoffmann-La Roche Ltd.
Novartis AG
Pfizer Inc.
Tarveda Therapeutics Inc.
Teva Pharmaceutical Industries Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Somatostatin Analogue Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Somatostatin Analogue Drug, with revenue, gross margin and global market share of Somatostatin Analogue Drug from 2018 to 2023.
Chapter 3, the Somatostatin Analogue Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Somatostatin Analogue Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Somatostatin Analogue Drug.
Chapter 13, to describe Somatostatin Analogue Drug research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Somatostatin Analogue Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Somatostatin Analogue Drug by Type
        1.3.1 Overview: Global Somatostatin Analogue Drug Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Somatostatin Analogue Drug Consumption Value Market Share by Type in 2022
        1.3.3 Octreotide
        1.3.4 Lanreotide
        1.3.5 Pasireotide
    1.4 Global Somatostatin Analogue Drug Market by Application
        1.4.1 Overview: Global Somatostatin Analogue Drug Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Acromegaly
        1.4.3 Neuroendocrine Tumor (NET)
        1.4.4 Others
    1.5 Global Somatostatin Analogue Drug Market Size & Forecast
    1.6 Global Somatostatin Analogue Drug Market Size and Forecast by Region
        1.6.1 Global Somatostatin Analogue Drug Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Somatostatin Analogue Drug Market Size by Region, (2018-2029)
        1.6.3 North America Somatostatin Analogue Drug Market Size and Prospect (2018-2029)
        1.6.4 Europe Somatostatin Analogue Drug Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Somatostatin Analogue Drug Market Size and Prospect (2018-2029)
        1.6.6 South America Somatostatin Analogue Drug Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Somatostatin Analogue Drug Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 Camurus AB
        2.1.1 Camurus AB Details
        2.1.2 Camurus AB Major Business
        2.1.3 Camurus AB Somatostatin Analogue Drug Product and Solutions
        2.1.4 Camurus AB Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Camurus AB Recent Developments and Future Plans
    2.2 Chiasma
        2.2.1 Chiasma Details
        2.2.2 Chiasma Major Business
        2.2.3 Chiasma Somatostatin Analogue Drug Product and Solutions
        2.2.4 Chiasma Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Chiasma Recent Developments and Future Plans
    2.3 Ipsen Group
        2.3.1 Ipsen Group Details
        2.3.2 Ipsen Group Major Business
        2.3.3 Ipsen Group Somatostatin Analogue Drug Product and Solutions
        2.3.4 Ipsen Group Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Ipsen Group Recent Developments and Future Plans
    2.4 Boehringer Ingelheim International GmbH
        2.4.1 Boehringer Ingelheim International GmbH Details
        2.4.2 Boehringer Ingelheim International GmbH Major Business
        2.4.3 Boehringer Ingelheim International GmbH Somatostatin Analogue Drug Product and Solutions
        2.4.4 Boehringer Ingelheim International GmbH Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
    2.5 Eli Lilly & Co.
        2.5.1 Eli Lilly & Co. Details
        2.5.2 Eli Lilly & Co. Major Business
        2.5.3 Eli Lilly & Co. Somatostatin Analogue Drug Product and Solutions
        2.5.4 Eli Lilly & Co. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Eli Lilly & Co. Recent Developments and Future Plans
    2.6 F. Hoffmann-La Roche Ltd.
        2.6.1 F. Hoffmann-La Roche Ltd. Details
        2.6.2 F. Hoffmann-La Roche Ltd. Major Business
        2.6.3 F. Hoffmann-La Roche Ltd. Somatostatin Analogue Drug Product and Solutions
        2.6.4 F. Hoffmann-La Roche Ltd. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
    2.7 Novartis AG
        2.7.1 Novartis AG Details
        2.7.2 Novartis AG Major Business
        2.7.3 Novartis AG Somatostatin Analogue Drug Product and Solutions
        2.7.4 Novartis AG Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Novartis AG Recent Developments and Future Plans
    2.8 Pfizer Inc.
        2.8.1 Pfizer Inc. Details
        2.8.2 Pfizer Inc. Major Business
        2.8.3 Pfizer Inc. Somatostatin Analogue Drug Product and Solutions
        2.8.4 Pfizer Inc. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Pfizer Inc. Recent Developments and Future Plans
    2.9 Tarveda Therapeutics Inc.
        2.9.1 Tarveda Therapeutics Inc. Details
        2.9.2 Tarveda Therapeutics Inc. Major Business
        2.9.3 Tarveda Therapeutics Inc. Somatostatin Analogue Drug Product and Solutions
        2.9.4 Tarveda Therapeutics Inc. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Tarveda Therapeutics Inc. Recent Developments and Future Plans
    2.10 Teva Pharmaceutical Industries Ltd. 
        2.10.1 Teva Pharmaceutical Industries Ltd. Details
        2.10.2 Teva Pharmaceutical Industries Ltd. Major Business
        2.10.3 Teva Pharmaceutical Industries Ltd. Somatostatin Analogue Drug Product and Solutions
        2.10.4 Teva Pharmaceutical Industries Ltd. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Somatostatin Analogue Drug Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Somatostatin Analogue Drug by Company Revenue
        3.2.2 Top 3 Somatostatin Analogue Drug Players Market Share in 2022
        3.2.3 Top 6 Somatostatin Analogue Drug Players Market Share in 2022
    3.3 Somatostatin Analogue Drug Market: Overall Company Footprint Analysis
        3.3.1 Somatostatin Analogue Drug Market: Region Footprint
        3.3.2 Somatostatin Analogue Drug Market: Company Product Type Footprint
        3.3.3 Somatostatin Analogue Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Somatostatin Analogue Drug Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Somatostatin Analogue Drug Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
    5.1 Global Somatostatin Analogue Drug Consumption Value Market Share by Application (2018-2023)
    5.2 Global Somatostatin Analogue Drug Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Somatostatin Analogue Drug Consumption Value by Type (2018-2029)
    6.2 North America Somatostatin Analogue Drug Consumption Value by Application (2018-2029)
    6.3 North America Somatostatin Analogue Drug Market Size by Country
        6.3.1 North America Somatostatin Analogue Drug Consumption Value by Country (2018-2029)
        6.3.2 United States Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        6.3.3 Canada Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        6.3.4 Mexico Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Somatostatin Analogue Drug Consumption Value by Type (2018-2029)
    7.2 Europe Somatostatin Analogue Drug Consumption Value by Application (2018-2029)
    7.3 Europe Somatostatin Analogue Drug Market Size by Country
        7.3.1 Europe Somatostatin Analogue Drug Consumption Value by Country (2018-2029)
        7.3.2 Germany Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        7.3.3 France Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        7.3.5 Russia Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        7.3.6 Italy Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Somatostatin Analogue Drug Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Somatostatin Analogue Drug Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Somatostatin Analogue Drug Market Size by Region
        8.3.1 Asia-Pacific Somatostatin Analogue Drug Consumption Value by Region (2018-2029)
        8.3.2 China Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        8.3.3 Japan Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        8.3.4 South Korea Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        8.3.5 India Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        8.3.7 Australia Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Somatostatin Analogue Drug Consumption Value by Type (2018-2029)
    9.2 South America Somatostatin Analogue Drug Consumption Value by Application (2018-2029)
    9.3 South America Somatostatin Analogue Drug Market Size by Country
        9.3.1 South America Somatostatin Analogue Drug Consumption Value by Country (2018-2029)
        9.3.2 Brazil Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        9.3.3 Argentina Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Somatostatin Analogue Drug Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Somatostatin Analogue Drug Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Somatostatin Analogue Drug Market Size by Country
        10.3.1 Middle East & Africa Somatostatin Analogue Drug Consumption Value by Country (2018-2029)
        10.3.2 Turkey Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
        10.3.4 UAE Somatostatin Analogue Drug Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Somatostatin Analogue Drug Market Drivers
    11.2 Somatostatin Analogue Drug Market Restraints
    11.3 Somatostatin Analogue Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Somatostatin Analogue Drug Industry Chain
    12.2 Somatostatin Analogue Drug Upstream Analysis
    12.3 Somatostatin Analogue Drug Midstream Analysis
    12.4 Somatostatin Analogue Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Somatostatin Analogue Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?